VGLL3 expression is associated with a tumor suppressor phenotype in epithelial ovarian cancer.

Mol Oncol 2013 Jun 16;7(3):513-30. Epub 2013 Jan 16.

Department of Human Genetics, McGill University, Montreal General Hospital, 1650 Cedar Avenue, Montreal H3G 1A4, Quebec, Canada.

Previous studies have implicated vestigial like 3 (VGLL3), a chromosome 3p12.3 gene that encodes a putative transcription co-factor, as a candidate tumor suppressor gene (TSG) in high-grade serous ovarian carcinomas (HGSC), the most common type of epithelial ovarian cancer. A complementation analysis based on microcell-mediated chromosome transfer (MMCT) using a centric fragment of chromosome 3 (der3p12-q12.1) into the OV-90 ovarian cancer cell line haploinsufficient for 3p and lacking VGLL3 expression was performed to assess the effect on tumorigenic potential and growth characteristics. Genetic characterization of the derived MMCT hybrids revealed that only the hybrid that contained an intact VGLL3 locus exhibited alterations of tumorigenic potential in a nude mouse xenograft model and various in vitro growth characteristics. Only stable OV-90 transfectant clones expressing low levels of VGLL3 were derived. These clones exhibited an altered cytoplasmic morphology characterized by numerous single membrane bound multivesicular-bodies (MVB) that were not attributed to autophagy. Overexpression of VGLL3 in OV-90 was achieved using a lentivirus-based tetracycline inducible gene expression system, which also resulted in MVB formation in the infected cell population. Though there was no significant differences in various in vitro and in vivo growth characteristics in a comparison of VGLL3-expressing clones with empty vector transfectant controls, loss of VGLL3 expression was observed in tumors derived from mouse xenograft models. VGLL3 gene and protein expression was significantly reduced in HGSC samples (>98%, p < 0.05) relative to either normal ovarian surface epithelial cells or epithelial cells of the fallopian tube, possible tissues of origin of HGSC. Also, there appeared to be to be more cases with higher staining levels in stromal tissue component from HGSC cases that had a prolonged disease-free survival. The results taken together suggest that VGLL3 is involved in tumor suppressor pathways, a feature that is characterized by the absence of VGLL3 expression in HGSC samples.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molonc.2012.12.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5528482PMC
June 2013
22 Reads

Publication Analysis

Top Keywords

vgll3 expression
16
ovarian cancer
12
tumor suppressor
12
growth characteristics
12
vgll3
10
tumorigenic potential
8
mouse xenograft
8
epithelial ovarian
8
hgsc samples
8
epithelial cells
8
hgsc
5
ovarian
5
expression
5
overexpression vgll3
4
ov-90 achieved
4
vgll3 ov-90
4
mvb attributed
4
attributed autophagy
4
bound multivesicular-bodies
4
autophagy overexpression
4

References

(Supplied by CrossRef)
Current management strategies for ovarian cancer
Aletti et al.
Mayo Clin. Proc. 2007
Ovarian surface epithelium: biology, endocrinology, and pathology
Auersperg et al.
Endocr. Rev. 2001

Similar Publications